Hepatic resection: an analysis of the impact of operative and perioperative factors on morbidity and mortality rates in 2008 consecutive hepatectomy cases
- PMID: 20079125
Hepatic resection: an analysis of the impact of operative and perioperative factors on morbidity and mortality rates in 2008 consecutive hepatectomy cases
Abstract
Background: Hepatectomy is a standard hepatic surgical technique. The safety of hepatectomy has been improved in line with improvements in surgical techniques. This study analyzed the operative and perioperative factors associated with hepatectomy.
Methods: A total of 2008 patients who underwent consecutive hepatectomies between January 1986 and December 2005 were investigated retrospectively. Diagnoses were made based on pathological findings.
Results: Malignant and benign liver diseases accounted for 58.5% and 41.2%, respectively, of the conditions requiring resections. Primary liver cancers accounted for 76.1% of the malignant tumors, while hilar cholangiocarcinomas accounted for 6.7%. Hemangiomas (41.7%) and hepatolithiasis (29.6%) were the most common of the benign conditions. Microwave in-line coagulation was used in 236 of our liver resection cases. The overall postoperative complication rate was 14.44%, of which 12.54% of resections were performed for primary liver cancer, 16.40% for secondary liver cancer, and 16.32% for hepatolithiasis. The overall hospital mortality was 0.55%, and that for malignant liver disease was 0.51%. A high mortality (2.53%) was associated with extensive liver resections for hilar cholangiocarcinomas (two deaths in 79 cases). Microwave in-line pre-coagulation resection, Child-Pugh grading, operating time, postoperative length of stay, and preoperative serum albumin level were independent predictors of morbidity. Blood loss, Child-Pugh grading, operating time and preoperative serum albumin level were independent predictors of mortality.
Conclusions: Hepatectomy can be performed safely with low morbidity and mortality, provided that it is carried out with optimal perioperative management and innovative surgical techniques.
Similar articles
-
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade.Ann Surg. 2002 Oct;236(4):397-406; discussion 406-7. doi: 10.1097/01.SLA.0000029003.66466.B3. Ann Surg. 2002. PMID: 12368667 Free PMC article.
-
[Liver resection: single center experiences of 2008 consecutive resections in 20 years].Zhonghua Wai Ke Za Zhi. 2008 Sep 1;46(17):1314-21. Zhonghua Wai Ke Za Zhi. 2008. PMID: 19094562 Chinese.
-
Getting started as a hepatobiliary surgeon: lessons learned from the first 100 hepatectomies as a consultant.N Z Med J. 2005 Feb 25;118(1210):U1322. N Z Med J. 2005. PMID: 15776098
-
Hepatic resections: changing mortality and morbidity.Am Surg. 1994 Oct;60(10):748-52. Am Surg. 1994. PMID: 7944036 Review.
-
[Management of complications after liver resection].Zentralbl Chir. 2010 Apr;135(2):112-20. doi: 10.1055/s-0030-1247331. Epub 2010 Apr 8. Zentralbl Chir. 2010. PMID: 20379940 Review. German.
Cited by
-
Case report: Sclerosed hemangioma of the liver: A diagnostic challenge.Front Surg. 2022 Dec 29;9:985849. doi: 10.3389/fsurg.2022.985849. eCollection 2022. Front Surg. 2022. PMID: 36644528 Free PMC article.
-
[Liver transection: modern procedure: Technique, results and costs].Chirurg. 2015 Jun;86(6):552-60. doi: 10.1007/s00104-014-2892-x. Chirurg. 2015. PMID: 25298187 Review. German.
-
National trends in discharge disposition after hepatic resection for malignancy.HPB (Oxford). 2011 Feb;13(2):96-102. doi: 10.1111/j.1477-2574.2010.00251.x. HPB (Oxford). 2011. PMID: 21241426 Free PMC article.
-
Situs Inversus Totalis (SIT) with Hepatocellular Carcinoma (HCC): A Rare Case Report and Review of 12 Other Cases.Indian J Surg. 2013 Dec;75(6):424-9. doi: 10.1007/s12262-012-0744-9. Epub 2012 Oct 10. Indian J Surg. 2013. PMID: 24465096 Free PMC article. Review.
-
Is neoadjuvant chemotherapy necessary for patients with initially resectable colorectal liver metastases in the era of effective chemotherapy?Korean J Hepatobiliary Pancreat Surg. 2011 Nov;15(4):206-17. doi: 10.14701/kjhbps.2011.15.4.206. Epub 2011 Dec 15. Korean J Hepatobiliary Pancreat Surg. 2011. PMID: 26421041 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources